[Doxium tolerance after 1 year's uninterrupted treatment].
D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D001557:Benzenesulfonates / Q000494:pharmacology* / Q000627:therapeutic use; D001663:Bilirubin / Q000097:blood; D001769:Blood / Q000187:drug effects; D001772:Blood Cell Count; D001806:Blood Urea Nitrogen; D002784:Cholesterol / Q000097:blood; D003920:Diabetes Mellitus / Q000188:drug therapy; D006490:Hemostatics / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D006873:Hydroquinones / Q000494:pharmacology / Q000627:therapeutic use; D008099:Liver / Q000187:drug effects* / Q000201:enzymology; D013943:Thymol / Q000097:blood; D014652:Vascular Diseases / Q000188:drug therapy
D001557:Benzenesulfonates; D006490:Hemostatics; D006873:Hydroquinones; D013943:Thymol; D002784:Cholesterol; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D001663:Bilirubin
Tolérance du doxium après traitement ininterrompu d'une année.